Michael A Metzger

Chief Executive Officer, Director, Syndax Pharmaceuticals Inc

Bought, 12 months

$0.0M

Sold, 12 months

$1.4M

Companies

Latest trade

Jul 8, 2026

Companies

Syndax Pharmaceuticals IncChief Executive Officer, Director −$1.4M

Trades

SNDX Sold 32,375 shares at $24.24 · planned $0.8M Jul 8

SNDX Sold 6,847 shares at $18.99 $0.1M Jun 1

SNDX Sold 17,159 shares at $21.03 $0.4M Feb 9

SNDX Sold 7,412 shares at $20.62 $0.2M Feb 6

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.